Literature DB >> 11994772

Thyroid uptake and scintigraphy using 99mTc pertechnetate: standardization in normal individuals.

Celso Darío Ramos1, Denise Engelbrecht Zantut Wittmann, Elba Cristina Sá de Camargo Etchebehere, Marcos Antonio Tambascia, Cleide Aparecida Moreira Silva, Edwaldo Eduardo Camargo.   

Abstract

CONTEXT: Thyroid uptake and scintigraphy using 99mTc-pertechnetate has proven to be more advantageous than with 131I-iodide, since the images have better quality, the procedure is faster and the patient is submitted to a lower radiation dose.
OBJECTIVE: The purpose of this study was to standardize a simple and fast methodology for performing thyroid uptake and scintigraphy and to determine the normal values for 99mTc- pertechnetate uptake. TYPE OF STUDY: Prospective, non-randomized.
SETTING: Division of Nuclear Medicine, Department of Radiology, School of Medical Sciences, Campinas State University. PARTICIPANTS: The study consisted of 47 normal individuals, 30 women and 17 men, with ages ranging from 19 to 61 years (mean of 33 years). PROCEDURES: The laboratory assessment of thyroid function consisted of serum dosages of ultra-sensitive thyroxin and thyrotrophin. Twenty minutes after an intravenous injection of 10 mCi (370 MBq) of 99mTc-pertechnetate, the images were obtained on a computerized scintillation camera equipped with a low-energy high-resolution parallel hole collimator.
RESULTS: All the individuals were euthyroid both on clinical and laboratory evaluation. The baseline thyroid 99mTc-pertechnetate uptake ranged from 0.4 to 1.7%. The uptake values obtained in these normal individuals showed that 95% presented a thyroid uptake that ranged from 0.4 to 1.5% of the injected dose.
CONCLUSION: The assessment of thyroid structure and function using 99mTc-pertechnetate is a simple, fast and efficient method, which could easily become a part of the routine studies in nuclear medicine laboratories.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11994772     DOI: 10.1590/s1516-31802002000200004

Source DB:  PubMed          Journal:  Sao Paulo Med J        ISSN: 1516-3180            Impact factor:   1.044


  10 in total

1.  Value of ultrasound and cytological classification system to predict the malignancy of thyroid nodules with indeterminate cytology.

Authors:  Frederico Fernandes Ribeiro Maia; Patrícia S Matos; Elizabeth J Pavin; José Vassallo; Denise E Zantut-Wittmann
Journal:  Endocr Pathol       Date:  2011-06       Impact factor: 3.943

2.  Value of repeat ultrasound-guided fine-needle aspiration in thyroid nodule with a first benign cytologic result: impact of ultrasound to predict malignancy.

Authors:  Frederico F R Maia; Patrícia S Matos; Elizabeth J Pavin; José Vassallo; Denise E Zantut-Wittmann
Journal:  Endocrine       Date:  2011-04-16       Impact factor: 3.633

3.  Comparison of 99mTc Pertechnetate Thyroid Uptake Rates by Gamma Probe and Gamma Camera Methods for Differentiating Graves' Disease and Thyroiditis.

Authors:  Meihua Jin; Jonghwa Ahn; Seong-Gil Jo; Jangwon Park; Min Ji Jeon; Won Gu Kim; Tae Yong Kim; Won Bae Kim; Young Kee Shong; Jin-Sook Ryu
Journal:  Nucl Med Mol Imaging       Date:  2022-01-07

4.  Role of ultrasound, clinical and scintigraphyc parameters to predict malignancy in thyroid nodule.

Authors:  Frederico F R Maia; Patrícia S Matos; Bradley P Silva; Ana T Pallone; Elizabeth J Pavin; José Vassallo; Denise E Zantut-Wittmann
Journal:  Head Neck Oncol       Date:  2011-03-22

5.  Prognostic value of (99m)Tc-pertechnetate thyroid scintigraphy in radioiodine therapy in a cohort of Chinese Graves' disease patients: a pilot clinical study.

Authors:  Haifeng Hou; Shu Hu; Rong Fan; Wen Sun; Xiaofei Zhang; Mei Tian
Journal:  Biomed Res Int       Date:  2015-03-24       Impact factor: 3.411

6.  Comparison of thyroid blood flow and uptake indices using technetium-99m pertechnetate in patients with graves' disease and euthyroid subjects.

Authors:  Hamid Javadi; Ali Mahmoud Pashazadeh; Mehdi Mogharrabi; Iraj Nabipour; Mohammadreza Kalantarhormozi; Majid Assadi
Journal:  Mol Imaging Radionucl Ther       Date:  2014-10-05

7.  Genotype-phenotype correlations of dyshormonogenetic goiter in children and adolescents from South India.

Authors:  Bangaraiah Gari Ramesh; Panchangam Ramakanth Bhargav; Bangaraiah Gari Rajesh; Nangedda Vimala Devi; Rajagopalan Vijayaraghavan; Bhongir Aparna Varma
Journal:  Indian J Endocrinol Metab       Date:  2016 Nov-Dec

8.  Deep learning for intelligent diagnosis in thyroid scintigraphy.

Authors:  Tingting Qiao; Simin Liu; Zhijun Cui; Xiaqing Yu; Haidong Cai; Huijuan Zhang; Ming Sun; Zhongwei Lv; Dan Li
Journal:  J Int Med Res       Date:  2021-01       Impact factor: 1.671

9.  Fixed 30 mCi (1110 MBq) 131I-iodine therapy in autonomously functioning nodules: Single toxic nodule as a predictive factor of success.

Authors:  Lívia Stela Bueno Pereira; Cinthia Minatel Riguetto; Arnaldo Moura Neto; Marcos Antônio Tambascia; Celso Darío Ramos; Denise Engelbrecht Zantut-Wittmann
Journal:  World J Nucl Med       Date:  2021-11-25

10.  Inaccuracy of Thyroid to Background Uptake Ratio in Evaluating Technetium-99m-pertechnetate Thyroid Uptake and Establishing an Improved Algorithm.

Authors:  Changyin Wang; Yanfen Zhao; Ying Shen
Journal:  Asia Ocean J Nucl Med Biol       Date:  2019
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.